BlackRock Fund Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $66.2M | Buy |
1,490,258
+167,744
| +13% | +$7.45M | 0.01% | 1494 |
|
|
2016
Q3 | $47.7M | Buy |
1,322,514
+47,980
| +4% | +$1.73M | 0.01% | 1610 |
|
|
2016
Q2 | $17.5M | Buy |
1,274,534
+75,613
| +6% | +$1.04M | ﹤0.01% | 2100 |
|
|
2016
Q1 | $23M | Buy |
1,198,921
+44,935
| +4% | +$863K | 0.01% | 1901 |
|
|
2015
Q4 | $40.4M | Sell |
1,153,986
-81,894
| -7% | -$2.87M | 0.01% | 1623 |
|
|
2015
Q3 | $114M | Buy |
1,235,880
+196,771
| +19% | +$18.1M | 0.03% | 807 |
|
|
2015
Q2 | $91.3M | Sell |
1,039,109
-27,131
| -3% | -$2.38M | 0.02% | 1069 |
|
|
2015
Q1 | $79.1M | Buy |
1,066,240
+26,579
| +3% | +$1.97M | 0.02% | 1189 |
|
|
2014
Q4 | $58.2M | Buy |
1,039,661
+80,670
| +8% | +$4.52M | 0.01% | 1358 |
|
|
2014
Q3 | $43.5M | Buy |
958,991
+899
| +0.1% | +$40.8K | 0.01% | 1444 |
|
|
2014
Q2 | $39.7M | Buy |
958,092
+95,785
| +11% | +$3.97M | 0.01% | 1554 |
|
|
2014
Q1 | $59.7M | Buy |
862,307
+32,653
| +4% | +$2.26M | 0.02% | 1285 |
|
|
2013
Q4 | $50M | Buy |
829,654
+89,308
| +12% | +$5.38M | 0.02% | 1395 |
|
|
2013
Q3 | $45M | Buy |
740,346
+183,389
| +33% | +$11.2M | 0.02% | 1420 |
|
|
2013
Q2 | $37.3M | Buy |
+556,957
| New | +$37.3M | 0.01% | 1441 |
|